Genetically modified mouse models of adamantinomatous craniopharyngioma

Cynthia Lilian Andoniadou*, Juan Pedro Martinez-Barbera

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

1 Citation (Scopus)

Abstract

Over the last few years, there have been significant advances in the understanding of the pathogenesis of human adamantinomatous craniopharyngioma. Global and gene-specific expression studies of human biopsies have helped to delineate the network of pathways involved in the initiation and establishment of these tumours. Interestingly, genetically modified and patient-derived xenograft mouse models have revealed the function of some of the dysregulated pathways as well as identified a role for specific tumour cells in the formation of these neoplasias. It has emerged that undifferentiated embryonic precursors and adult pituitary stem cells are critical in the pathogenesis of murine tumours resembling human ACP. In this chapter, we aim to provide a general overview of pituitary development, since there is strong case for a developmental origin for human ACP. We also discuss the in vitro and in vivo evidence demonstrating the presence of stem cells inthe adult pituitary as well as their role of the pathogenesis of craniopharyngioma.

Original languageEnglish
Title of host publicationBasic Research and Clinical Aspects of Adamantinomatous Craniopharyngioma
PublisherSpringer International Publishing Switzerland
Pages41-55
Number of pages15
ISBN (Electronic)9783319518909
ISBN (Print)9783319518886
DOIs
Publication statusPublished - 19 Apr 2017

Keywords

  • Craniopharyngioma
  • Mouse models
  • Pituitary
  • Sox2
  • Stem cells
  • WNT pathway

Fingerprint

Dive into the research topics of 'Genetically modified mouse models of adamantinomatous craniopharyngioma'. Together they form a unique fingerprint.

Cite this